title: [Immediate and remote outcomes of hybrid and stage-wise treatment for concomitant pathology (heart defects and coronary artery disease in patients over 70 years old].
authors.forename: G V
authors.initials: GV
authors.lastname: Aniskevich
authors.forename: M L
authors.initials: ML
authors.lastname: Semenovskiĭ
authors.forename: V V
authors.initials: VV
authors.lastname: Chestukhin
authors.forename: P A
authors.initials: PA
authors.lastname: Vavilov
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D058385:Cardiac Valve Annuloplasty / Q000009:adverse effects / Q000379:methods; D003324:Coronary Artery Disease / Q000150:complications / Q000601:surgery; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications / Q000601:surgery; D006801:Humans; D008297:Male; D016343:Monitoring, Intraoperative / Q000379:methods; D009204:Myocardial Revascularization / Q000009:adverse effects / Q000379:methods; D010043:Outcome and Process Assessment, Health Care; D019990:Perioperative Care / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D020379:Risk Adjustment; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors